Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted Supply Disruption — Lupin Pharmaceuticals Inc. (L
Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted Supply Disruption — Lupin Pharmaceuticals Inc. (L is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted; Manufacturer: Lupin
| Drug name | Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted |
|---|---|
| Manufacturer | Lupin Pharmaceuticals Inc. |
| Recall/Disruption reason | Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stab |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1187-2014 |
| Initiation date | 20140127 |
| Quantity affected | 5,172 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →